EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Comment on: “Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence”

Zain Ali Nadeem iD, Abdulqadir J Nashwan iD

Brain and Behavior · 2024

DOI: 10.1002/brb3.3424 ↗

Kurz gefasst

Kommentar in der Zeitschrift Brain and Behavior, 2024. Verfasst von Zain Ali Nadeem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan. Hauptthemen laut MEDLINE: Alzheimer Disease, Gout, Hyperuricemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In an otherwise excellent paper, we find two methodological inaccuracies that might have overestimated the effect. First, the authors used a fixed-effect model for their meta-analysis. The fixed-effect model ignores any heterogeneity that may be present and gives a more precise effect estimate, but it may not be generalizable. In cases where considerable heterogeneity is present, the random effects model can be used. This model takes into account the different populations on which the individual studies were conducted (Deeks et al., 2019). Second, the authors used funnel plots, Begg's test, and Egger's test to assess the risk of publication bias. As a rule of thumb, the Cochrane Handbook for Systematic Reviews of Interventions recommends against using tests for funnel plot asymmetry when the number of included studies is less than 10 (Page et al., 2019). Additionally, visual inspection of funnel plot asymmetry is quite subjective and prone to errors (Terrin et al.,2005). The Doi plot and the Luis Furuya–Kanamori index are more sensitive to publication bias with less than 10 included studies (Furuya-Kanamori et al., 2018 and do not suffer from the difficulty in interpretation as do funnel plots. Other Information Published in: Brain and Behavior License: http://creativecommons.org/licenses/by/4.0/ See article on publisher's website: https://dx.doi.org/10.1002/brb3.3424

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGoutHyperuricemiaHumansRisk FactorsMeta-Analysis as Topic

Stichwörter der Autor:innen

alzheimer's diseasegouthyperuricemia

Autor:innen und Institutionen

  • Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
  • Hamad Medical Corporation, Doha, Qatar.

ORCID-Profile: Zain Ali Nadeem, Abdulqadir J Nashwan

Förderung

  • Qatar National Library

Zitieren

APA

Nadeem, Z. A., & Nashwan, A. J. (2024). Comment on: “Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence”. Brain and Behavior. https://doi.org/10.1002/brb3.3424

Vancouver

Nadeem ZA, Nashwan AJ. Comment on: “Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence”. Brain and Behavior. 2024. doi:10.1002/brb3.3424

BibTeX
@article{Nadeem2024,
  author = {Nadeem, Zain Ali and Nashwan, Abdulqadir J},
  title = {Comment on: “Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence”},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.3424}
}
Kostenlos starten →